Insider Selling: EVP, CLO, Corporate Secretary Alaleh Nouri Sells Shares of PROCEPT BioRobotics ...
PROCEPT BioRobotics(PRCT.US) Officer Sells US$621.76K in Common Stock
$PROCEPT BioRobotics(PRCT.US)$ Officer Nouri Alaleh sold 10,000 shares of common stock on Jun 17, 2024 at an average price of $62.1764 for a total value of $621.76K.Source: Announcement What is statem
Wells Fargo Maintains PROCEPT BioRobotics(PRCT.US) With Buy Rating, Maintains Target Price $67
Wells Fargo analyst Nathan Treybeck maintains $PROCEPT BioRobotics(PRCT.US)$ with a buy rating, and maintains the target price at $67.According to TipRanks data, the analyst has a success rate of 0.0%
Form 144 | PROCEPT BioRobotics(PRCT.US) Officer Proposes to Sell 631.7K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 17, $PROCEPT BioRobotics(PRCT.US)$ Officer Alalah Nouri intends to sell 10,000 shares of its common stock on Jun 17, with a total market value of approximately $631.7K.
Express News | Procept Biorobotics Announces New Cpt® Category I Code From the American Medical Association for Aquablation Therapy
Institutional Investors in PROCEPT BioRobotics Corporation (NASDAQ:PRCT) See US$284m Decrease in Market Cap Last Week, Although Long-term Gains Have Benefitted Them.
Key Insights Given the large stake in the stock by institutions, PROCEPT BioRobotics' stock price might be vulnerable to their trading decisions A total of 9 investors have a majority stake in the c
PROCEPT BioRobotics Announces New CPT Category I Code From the American Medical Association for Aquablation Therapy
SAN JOSE, Calif., June 17, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transf
Procept BioRobotics Insider Sold Shares Worth $1,777,499, According to a Recent SEC Filing
Hisham Shiblaq, Executive Vice President, Chief Commercial Officer, on June 10, 2024, sold 26,046 shares in Procept BioRobotics (PRCT) for $1,777,499. Following the Form 4 filing with the SEC, Shiblaq
PROCEPT BioRobotics(PRCT.US) Officer Sells US$1.78 Million in Common Stock
$PROCEPT BioRobotics(PRCT.US)$ Officer Shiblaq Hisham sold 26,046 shares of common stock on Jun 10, 2024 at an average price of $68.2446 for a total value of $1.78 million.Source: Announcement What is
Form 144 | PROCEPT BioRobotics(PRCT.US) Officer Proposes to Sell 1.76 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 10, $PROCEPT BioRobotics(PRCT.US)$ Officer SHAM SHIBLAQ intends to sell 26,046 shares of its common stock on Jun 10, with a total market value of approximately $1.76 millio
PROCEPT BioRobotics to Present at Upcoming 2024 Truist Securities MedTech Conference on June 18, 2024
SAN JOSE, Calif., June 03, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative sol
PROCEPT BioRobotics (NASDAQ:PRCT) Has Debt But No Earnings; Should You Worry?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously said that 'Volatility is far from synonymous with risk.' So it might be obvious
PROCEPT BioRobotics to Present at Upcoming 2024 Leerink Partners Healthcare Crossroads Conference and 44th Annual William Blair Growth Stock Conference
SAN JOSE, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative solu
Alight, Novavax, and More Stocks See Action From Activist Investors
These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities. Subsequent changes in holdings or intentions must be reported in amended filings. This material is from May 2 through May 8, 2024. Source: VerityData
Analysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (PRCT), Amgen (AMGN) and Elevation Oncology (ELEV)
Unveiling 4 Analyst Insights On PROCEPT BioRobotics
4 analysts have shared their evaluations of PROCEPT BioRobotics (NASDAQ:PRCT) during the recent three months, expressing a mix of bullish and bearish perspectives.In the table below, you'll find a sum
PROCEPT BioRobotics Price Target Raised to $75.00/Share From $65.00 by TD Cowen
PROCEPT BioRobotics Price Target Raised to $75.00/Share From $65.00 by TD Cowen
Express News | Piper Sandler Maintains Overweight on PROCEPT BioRobotics, Raises Price Target to $75
Analysts Conflicted on These Healthcare Names: PROCEPT BioRobotics (PRCT), Springworks Therapeutics (SWTX) and Omnicell (OMCL)
Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF) and PROCEPT BioRobotics (PRCT)
No Data